Wipro reported consolidated revenue growth of 14.8% for Q4 FY27, led by its Biotechnology division, which contributed 33.9% of the total. Operating margin held at 5.9%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.
Export performance was a bright spot. Shipments to France rose 14.8%, helped by certification wins and shorter lead times from Kandla. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.
The numbers
Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.
Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2028, and disclosed that 33.9% of electricity at its main sites now comes from renewable sources under long-term contracts.
By the numbers
A new long-term agreement with Titan Company anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.
“The pact is not just volume; it is a joint roadmap for higher-value products.”
Expansion and capital allocation
Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.
Source: IGEN Intelligence analysis of ministry-level press releases data. Illustrative mock data.
The company also announced a new facility near Kandla, designed to add about 1,005 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.
| Segment | Revenue | YoY | Margin |
|---|---|---|---|
| Biotechnology (core) | $151M | +1.8% | 10.5% |
| Exports | $225M | +21.8% | 13.9% |
| Domestic retail | $47M | +6.8% | 25.1% |
| Services | $181M | +12.4% | 14.9% |
| Other | $411M | +14.3% | 15% |
Customers, contracts and exports
On the post-results call, management said the order book now stands at $8.9 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in France and South Korea. The chief financial officer described visibility as the best in five years.
Timeline of key events
- Results announced
Revenue up 14.8%; margin steady at 5.9%.
- Capex raised
Guidance moves to $8.9 billion to fund automation and debottlenecking.
- Supply pact signed
Multi-year agreement with Titan Company at index-linked pricing.
- Groundbreaking
Construction at the new facility near Kandla begins.
- First production
Targeted within 20 months of groundbreaking.
Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 33.9% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.
Expert commentary
“We are building where the customers are asking us to build. That is the simplest capital-allocation rule there is.”
“In my conversations with procurement heads, reliability is mentioned three times for every mention of price.”
“What matters now is execution. The announcements are in place; the next two quarters will show who can deliver.”
Risks and analyst view
Capital expenditure guidance was raised to $8.9 billion for the fiscal year, from $91 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 5.9% more output without additional land.
What it means for you
Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.
Expansion will lift procurement; engage early on qualification for the new lines.
Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.
About 1,200 direct roles and a technician academy are planned near Kandla; applications open with the state skills portal.
Companies and leaders in this story
Frequently asked questions
Sources
- Ministry-level press releases: Scheme guidelines and cabinet decisions
- IGEN Intelligence database: Proprietary tracker of announced projects
- UN Comtrade: Bilateral trade flows by HS code
- Central Board of Indirect Taxes & Customs: Port-level clearance and dwell data
Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.
